Paula
Rodríguez Otero
Consultora Médica
María José
Larráyoz Ilundáin
Clínico Asociado
Publikationen, an denen er mitarbeitet María José Larráyoz Ilundáin (2)
2024
-
The genomic profiling of high-risk smoldering myeloma patients treated with an intensive strategy unveils potential markers of resistance and progression
Blood cancer journal, Vol. 14, Núm. 1, pp. 74
2023
-
Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma
Nature Medicine, Vol. 29, Núm. 3, pp. 632-645